CTBO (Cantabio Pharmaceuticals) Total Assets: $0.33 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Total Assets?

Cantabio Pharmaceuticals CTBO Total Assets is $0.33 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2018 was $0.33 Mil.

Total Assets is connected with ROA %. Cantabio Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2018 was 788.51%. Total Assets is also linked to Revenue through Asset Turnover. Cantabio Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2018 was 0.00.

Cantabio Pharmaceuticals  (OTCPK:CTBO) Total Assets Explanation

Total Assets is connected with ROA %.

Cantabio Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2018 is

ROA %=Net Income (Q: Dec. 2018 )/( (Total Assets (Q: Sep. 2018 )+Total Assets (Q: Dec. 2018 ))/ count )
=1.372/( (0.022+0.326)/ 2 )
=1.372/0.174
=788.51 %

Note: The Net Income data used here is four times the quarterly (Dec. 2018) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cantabio Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2018 is

Asset Turnover
=Revenue (Q: Dec. 2018 )/( (Total Assets (Q: Sep. 2018 )+Total Assets (Q: Dec. 2018 ))/ count )
=0/( (0.022+0.326)/ 2 )
=0/0.174
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cantabio Pharmaceuticals Total Assets Related Terms

Cantabio Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Total Assets Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Total Assets
Get a 7-Day Free Trial 0.01 0.00 0.05 0.03 0.11

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.11 0.19 0.02 0.33

Cantabio Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cantabio Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2018 is calculated as

Total Assets=Total Equity (A: Mar. 2018 )+Total Liabilities (A: Mar. 2018 )
=-1.873+1.983
=0.11

Cantabio Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2018 is calculated as

Total Assets=Total Equity (Q: Dec. 2018 )+Total Liabilities (Q: Dec. 2018 )
=-1.889+2.215
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.33 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Total Assets of $0.33 Mil as of Dec. 2018. The total amount of assets as recorded on a company's balance sheet. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Total Assets too high?
Cantabio Pharmaceuticals' current Total Assets is $0.33 Mil.
How does Cantabio Pharmaceuticals' Total Assets compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Total Assets of $0.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Total Assets is $0.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Total Assets of $0.33 Mil. The current Total Assets is $0.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Total Assets is $0.33 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.